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[8] C. Michot, L. Hubert, M. Brivet, et al., LPIN1 gene mutations: a major cause of severe1 These authors contributed equally to this work.Rhabdomyolysis (RM) is characterized by acute and often severe
skeletal muscle damage resulting in myoglobinuria and, in severe
cases, acute renal failure [1]. In adults is typically due to trauma, intox-
ication or infection, whereas in children is frequently associated with
inherited muscle disorders [2]. LPIN1 mutations were identiﬁed as a
cause of severe recurrent RM, which usually begin in childhood, and in-
fections are the most frequent trigger [3,4]. LPIN1 spans 19 exons and
encodes lipin-1, an 890 amino acid protein predominantly expressed
in skeletal muscle and adipose tissue, which accounts for phosphatidic
acid phosphatase activity [2,5]. To date, 36 LPIN1mutations have been
described related with RM (Fig. 1a).
We report a 35-year-old female patient presenting myalgia, muscle
weakness, general fatigue and sleep apnea. Her ﬁrst child born from
an apparently non-consanguineous marriage (father already dead),
presented normal growth and psychomotor development until the
age of 2 years, when developed recurrent RM events precipitated by in-
fections, without symptoms and normal plasma creatine kinase be-
tween episodes. The child died at 4-year-old due to a crisis of RM
during gastroenteritis. A novel LPIN1 splicing mutation (c.2142-2
A N G) was identiﬁed in heterozygous state, in the index case, however,
her child was homozygous (Fig. 1b). This novel mutation is probably
pathogenic, predicted by bioinformatics tools, due to the break of accep-
tor site which affect the splicing mechanisms [6,7].
LPIN1mutations appear as the secondmost common cause of early-
onset RM, after primary fatty acid oxidation defects as a whole [8]. Het-
erozygous LPIN1mutations may also produce symptoms of cramps and
exercise-induced myalgia or mild muscular symptoms [2], as occurred
in our family.
This study allowed the identiﬁcation of the ﬁrst LPIN1 mutation in
Portuguese patients and corroborates the importance of a molecular
testing to conﬁrm LPIN1 patients (children and adults) with recurrent
RM.
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Fig. 1.— A) Schematic representation of describedmutations in LPIN1 gene. The new splicingmutation found in this study is shown in bold. B) LPIN1 splicingmutation (c.2142-2ANG) in
heterozygous and homozygous state, compared to the wild-type sequence.
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